The Role of Nitric Oxide, Lipocalin-2, and Proinflammatory Cytokines on Proteinuria and Insulin Resistance in Type 2 Diabetes Mellitus Subgroups
Chung Hyun Nahm,Moon Hee Lee,Noriyoshi Fujii,Tatsuyoshi Fujii,Jong Weon Choi
DOI: https://doi.org/10.2147/ijgm.s478584
IF: 2.145
2024-10-29
International Journal of General Medicine
Abstract:Chung Hyun Nahm, 1 Moon Hee Lee, 2 Noriyoshi Fujii, 3 Tatsuyoshi Fujii, 4 Jong Weon Choi 1 1 Department of Laboratory Medicine, College of Medicine, Inha University, Incheon, Republic of Korea; 2 Department of Internal Medicine, College of Medicine, Inha University, Incheon, Republic of Korea; 3 Department of Dermatology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan; 4 Department of Internal Medicine, Teikyo University Chiba Medical Center, Chiba, Japan Correspondence: Jong Weon Choi, Department of Laboratory Medicine, College of Medicine, Inha University, Inhang-ro 27, Jung-gu, Incheon, Republic of Korea, Tel +82-32-890-2503, Fax +82-32-890-2529, Email Background: Nitric oxide (NO) is a bioactive signaling molecule that mediates various physiological and biological processes. Type 2 diabetes mellitus (T2DM) can be categorized into several subgroups according to fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels. Few studies have closely examined the effect of NO and lipocalin-2 on albuminuria and insulin resistance in T2DM subgroups. This study investigated the role of NO, lipocalin-2, and proinflammatory cytokines on the development of proteinuria and insulin resistance in patients with T2DM subgroups. Methods: A total of 256 subjects, including 191 patients with T2DM and 65 non-diabetic healthy individuals, were evaluated. NO metabolites (NOx), lipocalin-2, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) levels were measured. Patients with T2DM were classified into three subgroups: patients with FPG-defined diabetes (PG-DM), those with HbA1c-defined diabetes (HA-DM), and those who met the criteria for both FPG and HbA1c (PG/HA-DM). The albumin-to-creatinine ratio (ACR) and the homeostasis model assessment of β-cell function (HOMA-B) and insulin resistance (HOMA-IR) were calculated. Results: NOx, lipocalin-2, and TNF-α levels were significantly higher in patients with T2DM than in healthy individuals. Patients with PG/HA-DM had significantly higher NOx levels than those with PG-DM or HA-DM. Of the patients with high NOx levels, patients with lipocalin-2 elevation exhibited higher ACR and HOMA-IR than those without lipocalin-2 elevation. NOx was positively correlated with lipocalin-2, ACR, HOMA-IR, and TNF-α but not with HOMA-B and IL-6. The upper quartile of NOx levels led to a 1.2-fold increase in the risk of albuminuria (odds ratio: 1.215; 95% CI: 1.012– 2.418; p < 0.001). Conclusion: NO plays a crucial role in proteinuria and insulin resistance by collaborating with lipocalin-2 and TNF-α, showing significantly higher levels in patients with PG/HA-DM than in those with PG-DM or HA-DM. Keywords: nitric oxide, lipocalin-2, proteinuria, insulin resistance, diabetes subgroups Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, elevated hemoglobin A1c (HbA1c), insulin resistance, and inadequate insulin secretion. 1 Prolonged hyperglycemia causes endothelial dysfunction, which induces micro- and macro-vascular complications, such as diabetic nephropathy, ischemic heart disease, and stroke. 2 In patients with T2DM, vascular inflammation and endothelial dysfunction usually precede the onset of microalbuminuria. 3 Vascular endothelial cells secrete diverse biological mediators, including nitric oxide (NO) and endothelin-1. 4 Hyperglycemia enhances NO production, which is closely related to T2DM with cardiovascular complications. 5 NO is a highly reactive free radical that plays a key role in various physiological processes, such as vasodilation, neurotransmission, immune responses, and apoptosis. 6 NO participates in the pathogenesis of inflammation, acting as a pro-inflammatory facilitator in pathological conditions and as an anti-inflammatory mediator in physiological conditions. 7 Proinflammatory cytokines induce expression of inducible NO synthase (iNOS) in macrophages and granulocytes, and activated iNOS promotes an approximately 1000-fold increase in NO production. 8 NO is produced in the pancreas and can affect insulin synthesis and secretion, contributing to the development of T2DM. 9 NO also plays an important role in lipocalin-2 production. 10 Lipocalin-2 is a member of the lipocalin superfamily and serves as a pleiotropic mediator of various physiological and pathological processes. 11 Lipocalin-2 also regulates glucose and lipid homeostasis, insulin secretion, and energy metabolism. 12 Lipocalin-2 is an acute-phase protein involved in regulating host responses to inflammation; thus, it has been regarded as an inflammatory marker. 13 Recently, li -Abstract Truncated-
medicine, general & internal